Secondary cytoreduction in epithelial ovarian cancer.
Morgan
M A
MA
Department of Obstetrics and Gynecology, University of Pennsylvania Medical Center, Philadelphia.
Rubin
S C
SC
D000206:Actuarial Analysis; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D007813:Laparotomy; D015337:Multicenter Studies as Topic; D009364:Neoplasm Recurrence, Local; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D010761:Phosphorus Radioisotopes / Q000627:therapeutic use; D018714:Radiotherapy, Adjuvant; D016032:Randomized Controlled Trials as Topic; D012086:Reoperation; D016879:Salvage Therapy; D016019:Survival Analysis; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D010761:Phosphorus Radioisotopes